Defining and Describing Benefit Appropriately in Clinical Trials
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 28 (4) , 332-343
- https://doi.org/10.1111/j.1748-720x.2000.tb00685.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Protecting Research Subjects — What Must Be DoneNew England Journal of Medicine, 2000
- What's the Price of a Research Subject? Approaches to Payment for Research ParticipationNew England Journal of Medicine, 1999
- Sense and nonsense:Schizophrenia Research, 1999
- Rewriting the "Points to Consider": The Ethical Impact of Guidance Document LanguageHuman Gene Therapy, 1999
- Genetic Research as Therapy: Implications of “Gene Therapy” for Informed ConsentJournal of Law, Medicine & Ethics, 1998
- Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaHuman Gene Therapy, 1994
- Life, Death, and the Insurance CompaniesNew England Journal of Medicine, 1994
- Uncertainty in Clinical ResearchLaw, Medicine and Health Care, 1988
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987
- The therapeutic misconception: Informed consent in psychiatric researchInternational Journal of Law and Psychiatry, 1982